FDA Cracks Down on Marijuana Cancer Treatment Claims
- Agency sends letters to 4 online sellers warning about claims
- ‘Deliberately prey on sick people with baseless claims:’ FDA
This article is for subscribers only.
U.S. officials sent a warning to the marijuana industry, alerting online sellers they cannot market their products as a treatment for cancer.
The Food and Drug Administration sent letters to four companies on Tuesday, warning them about unsubstantiated claims that their marijuana-derived products can combat tumors and kill cancer cells. The firms sell products including oils and capsules made from cannabidiol, also known as CBD, a component of the marijuana plant that doesn’t cause the mind-altering effects of the other main component, tetrahydrocannabinol, or THC.